Inventor · disambiguated record
In-San Kim
Also filed as: KIM IN S · KIM IN-SAN
30 granted patents·31 pending applications·60 citations·filing 2000–2025
95Inventor score
Files withKOREA INST SCI & TECH16KYUNGPOOK NAT UNIV IND ACAD8LEE BYUNG-HEON6KIM IN-SAN5REGEN BIOTECH INC5
Top patents by PatentIndex Score
61 records- 0190US11319360B2Exosome-based anticancer agentKOREA INST SCI & TECH·Filed 2017·Granted May 3, 2022·7 cites·12 claims
- 0284US7745410B2Bladder tumor-targeting peptide and use thereofKYUNGPOOK NAT UNIV IND ACAD·Filed 2007·Granted Jun 29, 2010·3 cites·8 claims
- 0383US12139713B2Therapeutic compounds for red blood cell-mediated delivery of an active pharmaceutical ingredient to a target cellKIST KOREA INSTITUTE OF SCIENCE AND TECH·Filed 2024·Granted Nov 12, 2024·0 cites·15 claims
- 0483US12006502B2Therapeutic compounds for red blood cell-mediated delivery of an active pharmaceutical ingredient to a target cellKIST KOREA INSTITUTE OF SCIENCE AND TECH·Filed 2024·Granted Jun 11, 2024·0 cites·8 claims
- 0583US11952412B2Exosome-based anticancer agentSHIFTBIO·Filed 2022·Granted Apr 9, 2024·1 cites·17 claims
- 0683US10501549B2Methods of inhibiting pathological angiogenesis with doppel-targeting moleculesSEOUL NAT UNIV R&DB FOUNDATION·Filed 2017·Granted Dec 10, 2019·3 cites·18 claims
- 0783US8217012B2Peptides for targeting apoptotic cells and uses thereofLEE BYUNG HEON·Filed 2009·Granted Jul 10, 2012·3 cites·17 claims
- 0883US2024360457A1Therapeutic Compounds for Red Blood Cell-Mediated Delivery of an Active Pharmaceutical Ingredient to a Target CellKIST KOREA INSTITUTE OF SCIENCE AND TECH·Filed 2024·Application pending·0 cites
- 0980US10202459B2Methods of inhibiting pathological angiogenesis with doppel-targeting moleculesSEOUL NAT UNIV R&DB FOUNDATION·Filed 2016·Granted Feb 12, 2019·2 cites·14 claims
- 1079US7250400B2Peptides and derivatives thereof showing cell attachment, spreading and detachment activityREGEN BIOTECH INC·Filed 2006·Granted Jul 31, 2007·2 cites·8 claims
- 1178US7511023B2Anticancer drug-chitosan complex forming self-aggregates and preparation method thereofKOREA INST SCI & TECH·Filed 2002·Granted Mar 31, 2009·12 cites·7 claims
- 1276US9409923B2Drug-fluorophore complex for specific detection of tumor cellsKOREA INST SCI & TECH·Filed 2013·Granted Aug 9, 2016·2 cites·3 claims
- 1375US8748398B2Stroke-targeting peptide and use thereofLEE BYUNG-HEON·Filed 2009·Granted Jun 10, 2014·3 cites·11 claims
- 1474US7968081B2Peptide for diagnosing, preventing and treating atherosclerosis and uses thereofKYUNGPOOK NAT UNIV IND ACAD·Filed 2008·Granted Jun 28, 2011·3 cites·17 claims
- 1573US10905774B2Nanocage and use thereofKOREA INST SCI & TECH·Filed 2019·Granted Feb 2, 2021·2 cites·27 claims
- 1673US2024209063A1Novel exosome-based anticancer agentSHIFTBIO INC·Filed 2024·Application pending·0 cites
- 1773US2024358645A1Novel recombinant exosome containing hyaluronidase and use thereofKOREA INST SCI & TECH·Filed 2024·Application pending·0 cites
- 1872US7070956B2Peptides and derivatives thereof showing cell attachment, spreading and detachment activityREGEN BIOTECH INC·Filed 2000·Granted Jul 4, 2006·1 cites·9 claims
- 1970US10513545B2Fusion polypeptide in which anti-inflammatory polypeptide and ferritin monomer fragment are bound and pharmaceutical composition for preventing and treating inflammatory diseases, containing same as active ingredientKYUNGPOOK NAT UNIV IND ACADEMIC COOP FOUND·Filed 2016·Granted Dec 24, 2019·1 cites·8 claims
- 2068US7919464B2Use of a peptide that interacts with αvβ3 integrin of endothelial cellKYUNGPOOK NAT UNIV IND ACAD·Filed 2004·Granted Apr 5, 2011·6 cites·10 claims
- 2168US7396682B2Method for cell adhesion and wound healingREGEN BIOTECH INC·Filed 2000·Granted Jul 8, 2008·3 cites·17 claims
- 2265US8975369B2Protein skeletal module which increases the binding affinity and binding specificity of active polypeptidesKYUNGPOOK NAT UNIV IND ACAD·Filed 2013·Granted Mar 10, 2015·1 cites·7 claims
- 2363US8900551B2Peptide which passes through blood-brain barrier and targets apoptosis of neurodegenerative brain disease site and uses thereofLEE BYUNG-HEON·Filed 2012·Granted Dec 2, 2014·1 cites·14 claims
- 2463US8133971B2Polypeptide specifically bound to phosphatidylserine and the use thereofLEE BYUNG-HEON·Filed 2009·Granted Mar 13, 2012·2 cites·5 claims
- 2562US2008015150A1Peptides and Derivatives Thereof Showing Cell Attachment, Spreading and Detachment ActivityKIM IN-SAN·Filed 2007·Application pending·0 cites
- 2660US9920105B2Human ferritin-derived fusion polypeptideKYUNGPOOK NAT UNIV IND ACADEMIC COOP FOUND·Filed 2015·Granted Mar 20, 2018·1 cites·26 claims
- 2760US2024325550A1Therapeutic Compounds for Inhibiting and Reducing the Expression of Cell Surface ProteinsKIST KOREA INSTITUTE OF SCIENCE AND TECH·Filed 2024·Application pending·0 cites
- 2858US2007167369A1Novel use of isolated polypeptide comprising four FAS-1 domains, EM1 domain and RGD motifKYUNGPOOK NAT UNIV IND ACAD·Filed 2007·Application pending·0 cites
- 2958US2022409550A1Pd-1-decorated nanocages and uses thereofKOREA INST SCI & TECH·Filed 2022·Application pending·0 cites
- 3057US2021393736A1Novel recombinant exosome and use thereofTANDEM CO LTD·Filed 2021·Application pending·0 cites
- 3156US2008274955A1Novel Use of a Polypeptide Comprising Fas-1 DomainKYUNGPOOK NAT UNIV IND ACAD·Filed 2004·Application pending·0 cites
- 3256US2019365653A1Novel recombinant exosome containing hyaluronidase and use thereofKOREA INST SCI & TECH·Filed 2018·Application pending·0 cites
- 3353US11246939B2Immunoregulatory protein-siRNA complex having anticancer activityKOREA INST SCI & TECH·Filed 2019·Granted Feb 15, 2022·0 cites·6 claims
- 3453US2023226215A1Novel recombinant exosome and use thereofKOREA INST SCI & TECH·Filed 2022·Application pending·0 cites
- 3552US2023381226A1Surface-engineered extracellular vesicles and therapeutic uses thereofSHIFTBIO INC·Filed 2023·Application pending·0 cites
- 3652US2024050523A1Method for inducing resolutive macrophage and uses therofSHIFTBIO INC·Filed 2023·Application pending·0 cites
- 3751US2018028600A1Novel recombinant exosome and use thereofKOREA INST SCI & TECH·Filed 2017·Application pending·0 cites
- 3851US2025302933A1Attenuated yet immunogenically potentiated tumor extracellular vesicle compositions and uses thereofKOREA INST SCI & TECH·Filed 2025·Application pending·0 cites
- 3950US10781238B2Human-derived ferritin monomer fragment and fusion polypeptide using sameKYUNGPOOK NAT UNIV IND ACADEMIC COOP FOUND·Filed 2016·Granted Sep 22, 2020·0 cites·4 claims
- 4050US2010331253A9Method for cell adhesion and wound healingKIM IN-SAN·Filed 2008·Application pending·0 cites
- 4149US7374776B2Bone-filling composition for stimulating bone-forming and bone-consolidation comprising calcium sulfate and viscous biopolymersREGEN BIOTECH INC·Filed 2002·Granted May 20, 2008·1 cites·6 claims
- 4249US2015051269A1Drug Delivery Conjugate Capable of Controlled Release, and Use ThereofPOSTECH ACAD IND FOUND·Filed 2013·Application pending·0 cites
- 4349US2025281415A1Exosomes expressing rsvf and use thereofKOREA INST SCI & TECH·Filed 2021·Application pending·0 cites
- 4448US2019307794A1Method for inducing transdifferentiation of immune cells based on exosomesKOREA INST SCI & TECH·Filed 2019·Application pending·0 cites
- 4548US2021054047A1Novel anticancer fusion protein and use thereofKOREA INST SCI & TECH·Filed 2020·Application pending·0 cites
- 4647US11261236B2Fusion peptide comprising thrombus-targeting peptide, ferritin fragment and thrombolytic peptide, and use thereofKYUNGPOOK NAT UNIV IND ACADEMIC COOP FOUND·Filed 2018·Granted Mar 1, 2022·0 cites·12 claims
- 4746US2008008755A1Pharmaceutical formulation of cholanic acid-chitosan complex incorporated with hydrophobic anticancer drugs and preparation method thereofKOREA INST SCI & TECH·Filed 2007·Application pending·0 cites
- 4845US9605038B2Fusion peptide comprising dhFas-1 domain and MMP substrate and use thereof for preventing and treating rheumatoid arthritisKYUNGPOOK NAT UNIV INDUSTRY-ACADEMIC COOP FOUND·Filed 2013·Granted Mar 28, 2017·0 cites·8 claims
- 4945US2012258038A1Uses of apoptotic cell-targeting peptides, label substances and liposomes containing a therapeutic agent for preventing, treating or therapeutically diagnosing apoptosis-related diseasesLEE BYUNG-HEON·Filed 2012·Application pending·0 cites
- 5045US2009214435A1Recombinant vector expressing MDR1 shRNA and thymidine kinase and use thereofKYUNGPOOK NAT UNIV IND ACAD·Filed 2008·Application pending·0 cites
Showing the top 50 of 61 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when In-San Kim files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →